Table 1. EPZ011989 in Vitro Data Summary.
property | analysis | units | EPZ011989 | |
---|---|---|---|---|
EZH2 activity | biochemical Ki | nM | <3 (WT) <3 (Y646) | |
ELISA H3K27me3 IC50a | nM | 94 ± 48 (n = 20) | ||
liver microsome clearance | scaled microsomal clearanceb | mL/min/kg (%Eh)c | human | 6 ± 0.5(29) |
rat | <10(<14) | |||
mouse | <10(<11) | |||
plasma protein binding | equilibrium dialysis | percent unbound | human | 97 ± 3 |
rat | 91 ± 6 | |||
mouse | 80 ± 11 | |||
LCC | 11d proliferation WSU-DLCL2 | nM | 208 ± 75 (n = 4) | |
predicted efficacious plasma exposured | nM (ng/mL) | human | 214(130) | |
rat | 223(135) | |||
mouse | 260(158) |
Enzyme-linked immunoassay measure of cellular methyl mark reduction.
Scaled according to the well-stirred liver model.
Percent hepatic extraction.
Plasma protein binding corrected LCC.